Antibodies
Showing 1–15 of 397 results
-
abagovomab
$3,603.02 – $6,303.02 -
abciximab
$3,603.02 – $6,303.02 -
Abelacimab (anti-Factor XI)
$80.87 – $1,309.37 -
AbGn-168H
$3,603.02 – $6,303.02 -
Abituzumab (anti-ITGAV)
$80.87 – $1,455.17 -
abrezekimab
$3,603.02 – $6,303.02 -
abrilumab
$3,603.02 – $6,303.02 -
Actoxumab (anti-Cdiff Toxin A)
$148.37 – $3,023.87 -
Adalimumab (anti-TNF-alpha)
$53.87 – $1,615.82 -
Aducanumab (anti-APP)
$67.37 – $1,131.17 -
AFM13
$3,603.02 – $6,303.02 -
Alemtuzumab (anti-CD52)
$107.87 – $2,690.42 -
Alirocumab (anti-PCSK9)
$202.37 – $3,723.17 -
ALT-803
$3,603.02 – $6,303.02 -
Amatuximab (anti-MSLN)
$67.37 – $1,336.37